Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
McKinsey
Colorcon
QuintilesIMS
US Army
Baxter
Mallinckrodt
AstraZeneca
Julphar

Generated: February 20, 2018

DrugPatentWatch Database Preview

Telavancin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for telavancin hydrochloride and what is the scope of telavancin hydrochloride patent protection?

Telavancin hydrochloride
is the generic ingredient in one branded drug marketed by Theravance Biopharma and is included in one NDA. There are eleven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Telavancin hydrochloride has one hundred and twenty-four patent family members in thirty-five countries.

Two suppliers are listed for this compound.
Summary for telavancin hydrochloride
Pharmacology for telavancin hydrochloride

US Patents and Regulatory Information for telavancin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-001 Sep 11, 2009 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-001 Sep 11, 2009 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-002 Sep 11, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-001 Sep 11, 2009 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-001 Sep 11, 2009 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-002 Sep 11, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-002 Sep 11, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-002 Sep 11, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-001 Sep 11, 2009 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-002 Sep 11, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for telavancin hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,265,086 Glycopeptide carboxy-saccharide derivatives ➤ Try a Free Trial
6,620,781 Glycopeptide carboxy-saccharide derivatives ➤ Try a Free Trial
6,831,150 Reductive alkylation process ➤ Try a Free Trial
7,026,288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin ➤ Try a Free Trial
7,244,705 Polyacid glycopeptide derivatives ➤ Try a Free Trial
6,872,804 Glycopeptide disulfide and thioester derivatives ➤ Try a Free Trial
6,903,070 Glycopeptide carboxy-saccharide derivatives ➤ Try a Free Trial
7,067,483 Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin ➤ Try a Free Trial
6,906,031 Polyacid glycopeptide derivatives ➤ Try a Free Trial
6,887,976 Glycopeptide phosphonate derivatives ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for telavancin hydrochloride

Supplementary Protection Certificates for telavancin hydrochloride

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2012002,C1292612 Lithuania ➤ Try a Free Trial PRODUCT NAME: TELAVANCINUM; REGISTRATION NO/DATE: EU/1/11/705/001, 2011 09 02 EU/1/11/705/002 20110902
C0051 France ➤ Try a Free Trial PRODUCT NAME: TELAVANCINE; REGISTRATION NO/DATE: EU/1/11/705/001-002 20110902
2011100062 Germany ➤ Try a Free Trial PRODUCT NAME: TELAVANCIN ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ HIERVON, EINSCHLIESSLICH TELAVANCINHYDROCHLORID; REGISTRATION NO/DATE: EU/1/11/705/001-002 20110902
90036-2 Sweden ➤ Try a Free Trial PRODUCT NAME: TELAVANCIN ELLER ETT FARMACEUTISKT GODTAGBART SALT DAERAV INNEFATTANDE TELAVANCINHYDROKLORID; REG. NO/DATE: EU/1/11/705/001 20110902
2011 00033 Denmark ➤ Try a Free Trial PRODUCT NAME: TELAVANCIN, ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER TELAVANCIN HYDROCHLORID
7 Finland ➤ Try a Free Trial
2012002 Lithuania ➤ Try a Free Trial PRODUCT NAME: TELAVANCINUM; REGISTRATION NO/DATE: EU/1/11/705/001, 2011 09 02 EU/1/11/705/002 20110902
/2011 Austria ➤ Try a Free Trial PRODUCT NAME: TELAVANCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ HIEVON, EINSCHLIESSLICH TELAVANCINHYDROCHLORID; REGISTRATION NO/DATE: EU/1/11/705/001-002 20110902
00507 Netherlands ➤ Try a Free Trial PRODUCT NAME: TELAVANCINE, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, INCLUSIEF TELAVANCINE HYDROCLORIDE; REGISTRATION NO/DATE: EU/1/11/705/001 - 002 20110902
908 Luxembourg ➤ Try a Free Trial 91908, EXPIRES: 20260501
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Chubb
Cipla
Julphar
Harvard Business School
Baxter
Accenture
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot